CLARUS THERAPEUTICS HOLDINGS, INC. Earnings Per Share (Diluted)
CLARUS THERAPEUTICS HOLDINGS, INC. reported Earnings Per Share (Diluted) of -$0.24 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, diluted for the quarter ending 2022-06-30 was -$0.24.
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, diluted for the quarter ending 2021-12-31 was -$0.47, a 157.39% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, diluted for the quarter ending 2021-09-30 was -$0.26.
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, diluted for the quarter ending 2021-06-30 was $0.00.
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, diluted for fiscal 2021 was -$5.72.
- CLARUS THERAPEUTICS HOLDINGS, INC. earnings per share, diluted for fiscal 2020 was -$8.20.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.24 10-Q · filed 2022-08-19 | -$0.75 10-Q · filed 2022-08-19 | ||
| 2021-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$4.68 derived: net income ÷ weighted average shares · filed 2022-08-19 | -$5.72 10-K · filed 2022-03-31 |
| 2021-09-30 | -$0.26 10-Q · filed 2021-11-19 | -$5.30 derived: net income ÷ weighted average shares · filed 2022-08-19 | -$5.68 10-Q · filed 2021-11-19 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-19 | $0.00 10-Q · filed 2022-08-19 | ||
| 2020-12-31 | $0.82 derived: net income ÷ weighted average shares · filed 2022-03-31 | $8.27 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$8.20 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$0.63 10-Q · filed 2021-11-19 | -$2.03 10-Q · filed 2021-11-19 |